Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study
Yu Song(East China Normal University), Junping Shi(Peking University), Shilong Xie(Zhejiang Medicine (China)), Ming‐Hua Zheng(Wenzhou Medical University), Yuqiang Mi(Tianjin Infectious Diseases Hospital), Fajuan Rui(Nanjing University of Chinese Medicine), Wen Xie(Capital Medical University), Fangping He(Zhejiang University), Xiaoling Chi(Guangzhou University of Chinese Medicine), Shufei Zang(Fudan University), Bihui Zhong(Sun Yat-sen University), Lang Bai(Southern Medical University), Yongfeng Yang(Shenyang Agricultural University), Jie Li(Nanjing University of Chinese Medicine), Jing Wang(Yantai University), Huiping Sheng, Jinjun Chen(Southern Medical University), Bingyuan Wang(Central South University), Jing Zhang(Children's Hospital of Fudan University), Xiaotang Fan(Army Medical University), Wenjing Ni(Nanjing Drum Tower Hospital), Yee Hui Yeo(Cedars-Sinai Medical Center)
Cited by 29
Related Papers
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|977
Initiation of Mammalian Liver Development from Endoderm by Fibroblast Growth Factors
|Science|1999|724
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2021|708